Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A.M. Mosconi
Observed names:
A.M Mosconi,
Annamaria Mosconi,
Mosconi, A M
Institution:
Azienda Ospedaliera di Perugia
Observed institutions:
Azienda Ospedaliera di Perugia,
Italian Oncology Group of Clinical Research,
Italian Association for Cancer Research,
University of Turin
ORCID:
0000-0002-5386-6049
Observed ORCID:
0000-0002-5386-6049
OpenAlex ID:
A5060958261
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
2024
·
P. Harter
, C. Marth
, et al.
·
Annals of Oncology
·
48
PDF
74 Salvage therapy with gemcitabine (GEM) in pretreated, advanced non-small cell lung cancer (NSCLC)
1997
·
L. Crinò
, A.M. Mosconi
, et al.
·
Lung Cancer
·
17
Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study
2020
·
Jennifer Foglietta
, Vienna Ludovini
, et al.
·
Genes
·
14
PDF
C-ERB-B2 expression as a predictor of outcome in a randomized trial comparing adjuvant CMF vs single-agent epirubicin in stage I-II breast cancer (BC) patients
1999
·
M. Colozza
, S. Gori
, et al.
·
European Journal of Cancer
·
12
1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
1995
·
L. Crinò
, G. Seagliotti
, et al.
·
European Journal of Cancer
·
11
Comparison of CMF (Cyclophosphamide, Methotrexate, and 5-Fluorouracil) With a Rotational Crossing and a Sequential Intensification Regimen in Advanced Breast Cancer: A Prospective Randomized Study
1999
·
Giorgio Cocconi
, Giancarlo Bisagni
, et al.
·
American Journal of Clinical Oncology
·
10
Gemcitabine in advanced pancreatic cancer: A phase II trial
1997
·
L. Crinò
, A.M. Mosconi
, et al.
·
European Journal of Cancer
·
5
A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report
2023
·
Mara Colombo
, Patrizia Mondini
, et al.
·
Frontiers in Oncology
·
4
Randomized phase II trial of NGR-hTNF with an anthracycline in platinum-refractory or -resistant ovarian cancer (OC).
2014
·
Domenica Lorusso
, Giovanni Scambia
, et al.
·
Journal of Clinical Oncology
·
2
Corrigendum: A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: a case report
2023
·
Mara Colombo
, Patrizia Mondini
, et al.
·
Frontiers in Oncology
PDF
Phase II study of paclitaxel and carboplatin for advanced Non-Small-Cell Lung-Cancer
2000
·
G.V Scagliotti
, S Novello
, et al.
·
Lung Cancer
P86 Epirubicin as a single agent in comparison to CMF in adjuvant therapy of stage I and II breast cancer
1998
·
M. Colozza
, G. Bisagni
, et al.
·
European Journal of Cancer
Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial
1998
·
Crinò, L
, Mosconi, A M
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Show more works
View as search
Works count:
13
Citation count:
123
H-index:
6
I10-index:
6
Year
Topic
Type
